SLE non-coding genetic risk variant determines the epigenetic dysfunction of an immune cell specific enhancer that controls disease-critical microRNA expression
Guojun Hou(Shanghai Jiao Tong University), Nan Shen(China-Japan Friendship Hospital)
Cited by 69
Related Papers
Low-dose interleukin-2 treatment selectively modulates CD4+ T cell subsets in patients with systemic lupus erythematosus
|Nature Medicine|2016|570
Functional rare and low frequency variants in BLK and BANK1 contribute to human lupus
|Nature Communications|2019|122
Single-cell profiling reveals distinct adaptive immune hallmarks in MDA5+ dermatomyositis with therapeutic implications
|Nature Communications|2022|112